Repligen | RGEN - Ebit


Repligen reported $16.81M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Agilent USD 443M 66M Sep/2025
Align Technology USD 184.65M 21.61M Sep/2025
Bio Techne USD 47.66M 71.52M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Bruker USD 83.9M 72M Sep/2025
Charles River Laboratories USD 133.8M 1.46M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Exact Sciences USD -25M 22.85M Sep/2025
General Electric Aerospace USD 1.68B 429M Dec/2025
Henry Schein USD 198M 2.25B Sep/2025
Illumina USD 250M 81M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
Mettler Toledo International USD 294.2M 28.77M Sep/2025
Myriad Genetics USD -5.5M 11.1M Mar/2025
Pfizer USD 4.57B 1.97B Sep/2025
Repligen USD 16.81M 10.85M Sep/2025
Revvity USD 98.34M 7.58M Sep/2025
Standard Biotools USD -32.89M 14.62M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Waters USD 192.11M 3.9M Sep/2025
West Pharmaceutical Services USD 167.6M 13.9M Sep/2025